Helicobacter pylori

Author:   Nayoung Kim
Publisher:   Springer Verlag, Singapore
Edition:   Softcover reprint of the original 1st ed. 2016
ISBN:  

9789811357060


Pages:   556
Publication Date:   09 December 2018
Format:   Paperback
Availability:   Manufactured on demand   Availability explained
We will order this item for you from a manufactured on demand supplier.

Our Price $362.22 Quantity:  
Add to Cart

Share |

Helicobacter pylori


Add your own review!

Overview

This book presents the current state of knowledge regarding the ability of Helicobacter pylori to colonize the gastrointestinal tract, the global epidemiology of H. pylori infection, transmission routes, the pathophysiology of H. pylori-related gastroduodenal and other diseases, diagnosis and treatment methods, guidelines for eradication, antibiotic resistance, the reinfection rate after H. pylori eradication, and animal models of H. pylori or related Helicobacter infection. The aim is to equip readers around the world with the understanding required in order to implement effective methods of H. pylori eradication and to enhance clinical outcomes for patients. The text is clearly written and is complemented by many helpful illustrations. This book will be a great asset in clinical practice for all practitioners who are involved in caring for patients with H. pylori-related diseases or have an interest in the subject. It will also be a useful source of information for medical students and for intelligent laypeople seeking information on H. pylori.

Full Product Details

Author:   Nayoung Kim
Publisher:   Springer Verlag, Singapore
Imprint:   Springer Verlag, Singapore
Edition:   Softcover reprint of the original 1st ed. 2016
Weight:   1.444kg
ISBN:  

9789811357060


ISBN 10:   9811357064
Pages:   556
Publication Date:   09 December 2018
Audience:   Professional and scholarly ,  Professional & Vocational
Format:   Paperback
Publisher's Status:   Active
Availability:   Manufactured on demand   Availability explained
We will order this item for you from a manufactured on demand supplier.

Table of Contents

Part 1. Epidemiology-Prevalence and Transmission routes of H. pylori.- Part 2. Pathophysiology.- 1) Colonization of H. pylori in the stomach.- 2) Brief description of Pathophysiology.- 3) Immune mechanism.- 4) Change of acid secretion, ghrelin and leptin by H. pylori.- 5) H. pylori virulence factors.- A: toxin (CagA, VacA, DupA, OipA, IceA).- B: genetic polymorphism of toxin and disease.- 6) Host factors: genetic polymorphism, etc.- Part 3. Diagnosis.- 1) Serology.- 2) Histology.- 3) Culture.- 4) UBT.- 5) Stool antigen.- 6) Specific conditions.- A: Children.- B: Bleeding.- Part 4. Symptom.- 1)Symptom of acute and chronic H. pylori infection.- Part 5. Disease.- 1) Atrophic gastritis and Intestinal metaplasia.- 2) Functional dyspepsia.- 3) Peptic ulcer.- 4) MALToma.- 5) Gastric cancer.- A: Synopsis and Epidemiology of gastric cancer.- B1: Pathogenesis: i.Genetic alternation (mutations in tumor-related genes) induced by Activation-induced cytidine deaminase (AID).- B2: Pathogenesis: ii. Epigenetic mechanisms: aberrant DNA methylation, microRNA.- B3: Pathogenesis:iii. Macrophage inhibitory factor (MIF).- B4: Pathogenesis: iv. Epidermal mesenchyme transition (EMT).- B5: Pathogenesis: v. ABO blood type.- B6: Pathogenesis: vi. First relatives of gastric cancer.- C: H. pylori-negative gastric cancer.- 6) Gastroesophageal reflux disease (GERD).- 7) NSAID-induced gastropathy and H. pylori infection.- 8) Extraintestinal manifestations of H. pylori infection.- A: Iron deficiency anemia.- B: Idiopathic thrombocytopenic purpura.- C: Heart disease.- D: Atopy and allergy.- Part 6. Antibiotic resistance.- 1) Synopsis of antibiotic resistance.- 2) Clarithromycin.- 3) Amoxicillin.- 4) Quinolone.- 5) Metronidazole.- Part 7. Treatment.- 1) Synopsis of antibiotic treatment.- 2) Triple therapy.- 3) Quadruple therapy.- 4) Sequential therapy.- 5) Concomitant therapy.- 6) Tailored therapy based on antibiotic resistance.- 7) Levofloxacin or rifabutin based triple therapy.- 8) Probiotics.- 9) Treatment guidelines.- 10) Screening method of early gastric cancer.- 11) Recrudescence and reinfection.- Part 8. Consequences of H. pylori eradication.- 1) Peptic ulcer disease.- 2) atrophic gastritis and Intestinal metaplasia.- 3) Gastric cancer.- Part 9. The effect of H. pylori on the other microbiota of stomach.- The effect of H. pylori on the other microbiota of stomach.- Part 10. Animal model- H. pylori, H. felis.

Reviews

Author Information

Nayoung Kim MD Ph.D., Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Republic of Korea

Tab Content 6

Author Website:  

Customer Reviews

Recent Reviews

No review item found!

Add your own review!

Countries Available

All regions
Latest Reading Guide

wl

Shopping Cart
Your cart is empty
Shopping cart
Mailing List